RECRUITING

The Effectiveness of Individualized Imagery Scripts on Sleep, Psychosis, and Suicidality Among Inpatients With Psychosis

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to see how feasible is the use of compact EEG and paired audio technology to administer sleep interventions for inpatients with psychosis, to see if individuals that receive individualized technology-based sleep interventions experience improvements in sleep quality and to see if individuals that receive individualized technology-based sleep interventions experience improvements in symptomatology

Official Title

The Effectiveness of Individualized Imagery Scripts on Sleep, Psychosis, and Suicidality Among Inpatients With Psychosis: A Randomized Control Pilot Study

Quick Facts

Study Start:2024-03-05
Study Completion:2026-06-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06194344

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * primary diagnoses of schizophrenia spectrum disorder or mood disorder with psychotic features, as determined by the treatment team or record review
  2. * capacity to consent to the study as determined by licensed psychologists ( or the primary attending psychiatrist
  3. * reported sleep dysfunction which will be determined by a subthreshold or more severe score ≥ 8 on the Insomnia Severity Index (ISI), and/or report experiencing nightmares at least once a week.
  1. * primary substance- or medical-induced psychosis
  2. * intellectual and developmental disabilities
  3. * neurodegenerative cognitive disorders
  4. * implanted devices (e.g., Pacemakers)
  5. * on one-to-one supervision or 15-minute safety checks for suicidality or aggression
  6. * patients with roommates that are on 15-minute checks to minimize impact on study participants' awakenings

Contacts and Locations

Study Contact

Alia Warner, Ph.D., ABPP
CONTACT
713-486-2700
Alia.R.Warner@uth.tmc.edu
Calvary Fielden, B.S.
CONTACT
713-741-6087
Calvary.R.Fielden@uth.tmc.edu

Principal Investigator

Alia Warner, Ph.D.
PRINCIPAL_INVESTIGATOR
The University of Texas Health Science Center, Houston
Jessica Badawi, Ph.D.
PRINCIPAL_INVESTIGATOR
The University of Texas Health Science Center, Houston

Study Locations (Sites)

The University of Texas Health Science Center at Houston
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: The University of Texas Health Science Center, Houston

  • Alia Warner, Ph.D., PRINCIPAL_INVESTIGATOR, The University of Texas Health Science Center, Houston
  • Jessica Badawi, Ph.D., PRINCIPAL_INVESTIGATOR, The University of Texas Health Science Center, Houston

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-03-05
Study Completion Date2026-06-01

Study Record Updates

Study Start Date2024-03-05
Study Completion Date2026-06-01

Terms related to this study

Keywords Provided by Researchers

  • sleep therapy
  • suicidality
  • psychosis

Additional Relevant MeSH Terms

  • Psychosis